Novel mechanisms and treatment of arrhythmia during resuscitation
Novel mechanisms and treatment of arrhythmia during resuscitation
批准号:
9886863
负责人:
KENNETH LAURITA
金额:
$66.9万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-04-10 至 2024-03-31
关键词:
AcuteArrhythmiaBiological MarkersBlood CirculationCardiacClinicalCollaborationsComplexCouplingDataDevelopmentDistressElectrocardiogramElectrophysiology (science)Emergency MedicineEmergency researchEnvironmentFunctional disorderFutureGap JunctionsHeartHeart ArrestHospitalsIschemiaLinkMachine LearningMechanicsMetabolicModelingMyocardial IschemiaMyocardiumOutcomePatientsPatternPhasePublic HealthReperfusion TherapyResuscitationRiskSumTechniquesTestingTherapeuticTranslatingTreatment EfficacyUnited StatesUnited States National Institutes of HealthVentricular FibrillationVentricular Tachycardiabaseeffective therapyepicardial mappinghemodynamicsimprovedimproved outcomein vivoin vivo Modelinsightinstrumentinstrumentationmortalitynovelnovel therapeuticspredictive markerpreventrearrestsignal processingtranslational model
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Resuscitation from sudden cardiac arrest (SCA) is typically initiated in patients with ongoing ischemia and ventricular
fibrillation (VF) or tachycardia (VT) that, even if successful, is commonly followed by repeated rearrest. Despite significant
efforts to improve resuscitation from SCA, survival remains poor prompting NIH to identify resuscitation as a high priority
for emergency care research. Beat-to-beat alternans of cellular repolarization in the myocardium (repolarization
alternans) is a substrate for arrhythmias, is rampant during resuscitation, and is manifested on the ECG as T-wave
oscillations that can alternate (2:1) or as more complex oscillations. In preliminary studies, we observed in resuscitation
patients and in an in vivo translational model of resuscitation from SCA, that rearrest due to VT/VF is preceded by T-wave
oscillations that are complex; whereas, rearrest due to pulseless electrical activity (PEA) is preceded by increased T-wave
oscillations that alternate. Accordingly, we contend that when T-wave oscillations are complex, repolarization alternans
in the myocardium is spatially discordant, which is repolarization alternans occurring out-of-phase in adjacent regions and
is highly arrhythmogenic. In contrast, when T-wave oscillations alternate, repolarization alternans in the myocardium is
spatially in-phase (concordant), which poses no known immediate arrhythmia risk but is associated with mechanical
dysfunction and, thus, PEA. Finally, in the absence of any repolarization alternans, risk of rearrest due to PEA or VT/VF is
low. We hypothesize that during resuscitation rearrest due to VT/VF or PEA is strongly linked to repolarization alternans
in the myocardium that is spatially discordant or not, respectively, and that specifically targeting the underlying
mechanisms can prevent rearrest due to VT/VF and, possibly, PEA. In addition, the full spectrum of ECG T-wave oscillations
can be utilized to predict no rearrest and rearrest from VT/VF or PEA and, thus, be used in the future as a biomarker to
guide therapy and significantly improve outcomes. Our hypotheses will be tested with the following aims. 1) Determine
the mechanistic relationship between cellular repolarization alternans and rearrest due to VT/VF or PEA in an in vivo model
of resuscitation. 2) Determine if targeting the mechanisms of repolarization alternans can prevent rearrest during
resuscitation, thereby gaining additional mechanistic insight. 3) Develop and test an ECG biomarker for predicting risk of
rearrest due to VT/VF and PEA in resuscitation patients. To achieve these aims, we will utilize sophisticated
instrumentation and signal processing in an in vivo translational model of resuscitation as well as in pre-hospital and in-
hospital resuscitation patients. We have also established a highly translational collaboration that combines expertise in
emergency medicine, cardiac arrhythmia, and clinical electrophysiology. Our scientific environment provides a unique
opportunity to develop a better understanding of arrhythmia mechanisms relevant to resuscitation in order to develop
novel and effective therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Electrophysiology Scientific Core 2
-
批准号:10410646
-
项目类别:
-
资助金额:$26.24万
-
财政年份:2022
-
负责人:KENNETH LAURITA
-
依托单位:
Electrophysiology Scientific Core 2
-
批准号:10646347
-
项目类别:
-
资助金额:$26.24万
-
财政年份:2022
-
负责人:KENNETH LAURITA
-
依托单位:
Novel mechanisms and treatment of arrhythmia during resuscitation
-
批准号:10608116
-
项目类别:
-
资助金额:$63.62万
-
财政年份:2020
-
负责人:KENNETH LAURITA
-
依托单位:
Novel mechanisms and treatment of arrhythmia during resuscitation
-
批准号:10376229
-
项目类别:
-
资助金额:$63.62万
-
财政年份:2020
-
负责人:KENNETH LAURITA
-
依托单位:
A novel, multiparametric cardiac safety assay using human myocytes
-
批准号:8522876
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2013
-
负责人:KENNETH LAURITA
-
依托单位:
A novel, multiparametric cardiac safety assay using human myocytes
-
批准号:8769228
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2013
-
负责人:KENNETH LAURITA
-
依托单位:
Targeted cell therapy for the treatment of ventricular tachycardia
-
批准号:7825845
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2009
-
负责人:KENNETH LAURITA
-
依托单位:
Targeted cell therapy for the treatment of ventricular tachycardia
-
批准号:7936150
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2009
-
负责人:KENNETH LAURITA
-
依托单位:
Electrophysiological and antiarrhythmic benefit of cell therapy for heart disease
-
批准号:7588883
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2007
-
负责人:KENNETH LAURITA
-
依托单位:
Electrophysiological and antiarrhythmic benefit of cell therapy for heart disease
-
批准号:7255054
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2007
-
负责人:KENNETH LAURITA
-
依托单位:
Electrophysiological and antiarrhythmic benefit of cell therapy for heart disease
-
批准号:7788190
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2007
-
负责人:KENNETH LAURITA
-
依托单位:
Electrophysiological and antiarrhythmic benefit of cell therapy for heart disease
-
批准号:7407563
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2007
-
负责人:KENNETH LAURITA
-
依托单位:
Ca Handling & Arrhythmias Associated with LQT Syndrome
-
批准号:6828275
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2002
-
负责人:KENNETH LAURITA
-
依托单位:
Ca Handling & Arrhythmias Associated with LQT Syndrome
-
批准号:6620572
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2002
-
负责人:KENNETH LAURITA
-
依托单位:
Ca Handling & Arrhythmias Associated with LQT Syndrome
-
批准号:6689601
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2002
-
负责人:KENNETH LAURITA
-
依托单位:
Ca Handling & Arrhythmias Associated with LQT Syndrome
-
批准号:6419120
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2002
-
负责人:KENNETH LAURITA
-
依托单位:
海外基金